Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.100
+0.020 (0.96%)
At close: Jan 16, 2026, 4:00 PM EST
2.100
0.00 (0.00%)
After-hours: Jan 16, 2026, 4:10 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $144.82 million as of January 16, 2026. Its market cap has increased by 309.61% in one year.
Market Cap
144.82M
Enterprise Value
115.08M
1-Year Change
309.61%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $144.82M, an increase of 581.13%. That is a compound annual growth rate of 44.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 143.45M | 3.48% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |